ARCHIVES

Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 1 | January 25, 2008

Download PDF Visit The Full Archive

Related Articles

IOM Recommends FDA Consolidate Each Drug’s Lifetime History

May 4, 2012

BMI May Be Prognostic Tool For Types Of Breast Cancer

March 28, 2008

NIH Panel finalizes Consensus Statement; Two Panelists Join In Minority Opinion

March 28, 1997

FDA Proposes New Nonclinical Lab Regs

November 26, 1976

ASCO Updates Clinical Recommendations On Use Of Bisphosphonates In Myeloma

May 25, 2007

ASCO Releases Guideline On Larynx Preservation

July 28, 2006